The study, published in the journal Virus Evolution, assessed whether, over the long term, the SARS-CoV-2 virus is likely to demonstrate an immune evasion capability on par with that of influenza viruses.
Serum Institute of India (SII), the world's biggest Covid-19 vaccine maker, is hopeful of launching its second vaccine for coronavirus — Covovax — by September this year, CEO Adar Poonawalla announced on Saturday.
Turkish President Recep Tayyip Erdogan said that his government plans to complete its nationwide vaccination program against the coronavirus pandemic in May or June.
The head of the World Health Organization is asking rich countries to donate at least 10 million coronavirus vaccines so the UN health agency can reach its goal of vaccination in all countries within the first 100 days of 2021.
The 200,000 doses of COVID-19 vaccines, announced as a gift by India for UN peacekeepers, left Mumbai in the early hours of Saturday and will arrive at Copenhagen, Denmark. They will then be distributed to all UN peacekeeping missions.
The Centre is planning to widen the scope of the COVID-19 immunisation drive by bringing more population groups under its ambit, Union Health Minister Harsh Vardhan said on Friday, days after everyone above 45 years was made eligible to get vaccinated from April 1.
India started supplying the vaccine doses to foreign countries on January 20. The first countries to receive such vaccines were from the neighbourhood.
AstraZeneca says its COVID-19 vaccine is 76 per cent effective after updating its analysis in wake of rebuke from US officials.
As many as 4.85 crore people have received anti-COVID-19 vaccine till now, with over 32.5 lakh taking it in the last 24 hours, the government told Rajya Sabha on Tuesday.
AstraZeneca reported that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated US study.
AZD1222 demonstrated statistically significant vaccine efficacy of 78.9 per cent in preventing symptomatic Covid-19 and 100 per cent efficacy in preventing severe or critical disease and hospitalisation, according to the NIH.
Asaduddin Owaisi on Monday received the first dose of Covid-19 vaccine, Covishield. Covishield is the Indian version of the AstraZeneca-Oxford drug.
AstraZeneca said its experts also identified no safety concerns related to the vaccine, including a rare blood clot that was identified in Europe.
The vaccines were sold to 14 African countries after South Africa suspended its planned usage to vaccinate healthcare workers when it was found to have limited efficacy against a new variant of the virus that became dominant in the country during a second wave of the pandemic towards the end of last year.
Beneficiaries need to register themselves on Co-WIN portal to get jabs. Those who do not have access to the Co-WIN portal can go to the centre and take COVID-19 vaccines.
Prime Minister Imran Khan has tested positive for the novel coronavirus days after receiving a dose of Chinese vaccine Sinopharm.
Bharat Biotech had applied for emergency use authorisation for its vaccine candidate, Covaxin, in Nepal on January 13. Covaxin demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials India.
India is witnessing its second wave of Covid-19 pandemic, with 39,670 fresh cases recorded on Thursday.
Pakistan Prime Minister Imran Khan on Friday received the first shot of vaccination against COVID-19 and urged the citizens of his country to ensure the full implementation of norms to prevent the surge in cases of coronavirus.
Spain, Cyprus, Italy, and France will resume administering the Oxford-AstraZeneca COVID-19 vaccine, after the European Medicines Agency (EMA) said it was 'safe and effective.'
Top News
Latest News
